| Patient | Leonardo da Vinci |
|---|---|
| Date of birth | 1961-04-24 |
| Identifiers | MRN HR-RE001-SYN; SSN (made up) 000-01-5297 |
| Document date | 2026-11-01 |
| Author | Beatrice Carrow-Asante, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Primary care visit for weakness, numbness, and curling of the ring and little fingers of the right hand after a fall onto the elbow, with same-day brain MRI and elbow X-ray. Concerns: He cannot hold the palette or a brush with his right hand and fears he will never paint again; He asks whether this is a stroke. [S]
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Acetaminophen 500 mg oral tablet, one or two tablets by mouth every 6 hours as needed for elbow pain, no more than 3 g a day | One or two tablets every 6 hours as needed; no more than six tablets a day | Oral route | 2026-08-03 to 2026-09-14 | completed | S |
| Atorvastatin 20 mg oral tablet, one tablet by mouth each evening | One tablet by mouth each evening | Oral route | 2026-08-17 | active | S |
| Procedure | Dates | Status | Evidence |
|---|---|---|---|
| MRI of the brain with diffusion-weighted imaging: no acute or old infarct, no hemorrhage, and no mass; mild age-appropriate white matter change | 2026-08-03 to 2026-08-03 | completed | S |
| Plain X-ray of the right elbow: no fracture or dislocation; a small osteophyte at the medial elbow; normal alignment | 2026-08-03 to 2026-08-03 | completed | S |
| Twelve-lead ECG: sinus rhythm at 72 per minute; normal intervals; no atrial fibrillation | 2026-08-03 to 2026-08-03 | completed | S |
| Nerve conduction studies of both arms: right ulnar motor conduction velocity 36 m/s across the elbow against 57 m/s in the forearm, with a 38 percent fall in amplitude across the elbow; right ulnar sensory and dorsal ulnar cutaneous responses reduced; median and radial studies and the left ulnar nerve normal | 2026-08-17 to 2026-08-17 | completed | S |
| Needle EMG of the right arm: fibrillation potentials and reduced recruitment in the first dorsal interosseous and abductor digiti minimi, milder changes in the flexor digitorum profundus to the little finger, normal flexor carpi ulnaris, and normal abductor pollicis brevis, extensor indicis, and C8 paraspinal muscles | 2026-08-17 to 2026-08-17 | completed | S |
| Ultrasound of the right elbow and ulnar nerve: nerve swollen at the medial epicondyle (cross-sectional area 14 mm2 against 7 mm2 in the forearm), no subluxation on flexion, no ganglion, cyst, or mass | 2026-08-17 to 2026-08-17 | completed | S |
| Fitting of a night elbow splint (elbow at about 45 degrees of flexion) and a daytime hand-based anti-claw splint for the ring and little fingers | 2026-08-17 to 2026-08-17 | completed | S |
| Date | Vaccine | Status | Evidence |
|---|---|---|---|
| 2022-03-14 | Recombinant zoster vaccine, two-dose series completed | completed | S |
| 2021-05-03 | Tdap vaccine | completed | S |
| 2026-10-01 | High-dose influenza vaccine, 2026-2027 season | completed | S |
| 2026-10-01 | Pneumococcal conjugate vaccine PCV20 | completed | S |
| 2026-10-01 | COVID-19 vaccine, 2026-2027 formula | completed | S |
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|---|---|
| From about 1473 | Left-handed for drawing and writing, with mirror writing from his early twenties; used the right hand for other work | D (CLM-0003) |
| Relative | Condition | Age at death | Evidence |
|---|---|---|---|
| father | A notary; his health and cause of death are not recorded in the cited sources | D (CLM-0002) | |
| mother | Known only by her first name; her health and cause of death are not recorded in the cited sources | D (CLM-0002) |
| Concern | Status | Evidence |
|---|---|---|
| He cannot hold the palette or a brush with his right hand and fears he will never paint again | active | S |
| He asks whether this is a stroke | active | S |
Most recent measures: Hemoglobin [Mass/volume] in Blood 14.8 on 2026-08-03; Leukocytes [#/volume] in Blood by Automated count 6.4 on 2026-08-03; Platelets [#/volume] in Blood by Automated count 228 on 2026-08-03; Sodium [Moles/volume] in Serum or Plasma 141 on 2026-08-03; Potassium [Moles/volume] in Serum or Plasma 4.4 on 2026-08-03; Creatinine [Mass/volume] in Serum or Plasma 0.98 on 2026-08-03; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 86 on 2026-08-03; Glucose [Mass/volume] in Serum or Plasma 96 on 2026-08-03; Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 21 on 2026-08-03; Hemoglobin A1c/Hemoglobin.total in Blood 5.5 on 2026-08-03; Cholesterol [Mass/volume] in Serum or Plasma 158 on 2026-10-20; Cholesterol in HDL [Mass/volume] in Serum or Plasma 51 on 2026-10-20; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 82 on 2026-10-20; Triglyceride [Mass/volume] in Serum or Plasma 124 on 2026-10-20; Lipoprotein a [Moles/volume] in Serum or Plasma 42 on 2026-08-03; Thyrotropin [Units/volume] in Serum or Plasma 2.2 on 2026-08-03; Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma 510 on 2026-08-03; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 on 2026-10-01 [S]
Strengths and supports: engagement in care [S]
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Weakness, numbness of the ring and little fingers, and curling of those fingers in the right hand for four weeks after a fall onto the right elbow, in a left-handed artist who uses the right hand for the palette and brushwork; stroke and a peripheral nerve lesion under evaluation | resolved | confirmed | R29.818 | S — Synthetic presenting concern; it echoes, without asserting, the paralysis of his right hand recorded later in 1517 (CLM-0006). Superseded by the diagnosis at the second visit. |
| One fall in the past year (slipped on stone stairs and landed on the right elbow), with no loss of consciousness, dizziness, or palpitations before it; fall risk | active | confirmed | Z91.81 | S — Synthetic fall that anchors the modern ulnar nerve injury; no historical fall is asserted. |
| Ulnar neuropathy at the right elbow (cubital tunnel), post-traumatic, moderately severe: sensory loss in the ulnar fingers and dorsal ulnar hand, weakness and early wasting of the intrinsic hand muscles with clawing of the ring and little fingers, focal slowing and partial conduction block across the elbow, and active denervation on EMG; stroke, C8 radiculopathy, and lower trunk plexopathy excluded | active | confirmed | G56.21 | S — Synthetic modern diagnosis. The paralysis of his right hand in 1517 is documented (D); its cause is unknown, and ulnar palsy, stroke, and median nerve palsy are competing retrospective readings (R). |
| Primary hypercholesterolemia (LDL 146 mg/dL) with a Pooled Cohort Equations 10-year ASCVD risk of 13.5 percent (PREVENT 6.9 percent); found on the stroke risk screen | active | confirmed | E78.00 | S — Synthetic risk factor found on the stroke risk screen; no historical lipid disorder is asserted. |
| Acute viral conjunctivitis, both eyes, after exposure to a student with red eyes; vision normal; resolved | resolved | confirmed | B30.9 | S — Synthetic intercurrent illness at an unscheduled visit; no historical eye disease is asserted. |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-08-03 | Hemoglobin [Mass/volume] in Blood | 14.8 | g/dL | 13.2-16.6 g/dL | Normal | S |
| 2026-08-03 | Leukocytes [#/volume] in Blood by Automated count | 6.4 | 10*3/uL | 3.4-9.6 10*3/uL | Normal | S |
| 2026-08-03 | Platelets [#/volume] in Blood by Automated count | 228 | 10*3/uL | 150-400 10*3/uL | Normal | S |
| 2026-08-03 | Sodium [Moles/volume] in Serum or Plasma | 141 | mmol/L | 135-145 mmol/L | Normal | S |
| 2026-08-03 | Potassium [Moles/volume] in Serum or Plasma | 4.4 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-08-03 | Creatinine [Mass/volume] in Serum or Plasma | 0.98 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 2026-08-03 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 86 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-08-03 | Glucose [Mass/volume] in Serum or Plasma | 96 | mg/dL | 70-99 mg/dL | Normal | S |
| 2026-08-03 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 21 | U/L | 7-55 U/L | Normal | S |
| 2026-08-03 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.5 | % | <=5.6% | Normal | S |
| 2026-08-03 | Cholesterol [Mass/volume] in Serum or Plasma | 222 | mg/dL | <=199 mg/dL | High | S |
| 2026-08-03 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 49 | mg/dL | >=40 mg/dL | Normal | S |
| 2026-08-03 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 146 | mg/dL | <=129 mg/dL | High | S |
| 2026-08-03 | Triglyceride [Mass/volume] in Serum or Plasma | 135 | mg/dL | <=149 mg/dL | Normal | S |
| 2026-08-03 | Lipoprotein a [Moles/volume] in Serum or Plasma | 42 | nmol/L | <=75 nmol/L | Normal | S |
| 2026-08-03 | Thyrotropin [Units/volume] in Serum or Plasma | 2.2 | m[IU]/L | 0.4-4 mIU/L | Normal | S |
| 2026-08-03 | Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma | 510 | pg/mL | 232-1245 pg/mL | Normal | S |
| 2026-10-01 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | {score} | S | ||
| 2026-10-20 | Cholesterol [Mass/volume] in Serum or Plasma | 158 | mg/dL | <=199 mg/dL | Normal | S |
| 2026-10-20 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 51 | mg/dL | >=40 mg/dL | Normal | S |
| 2026-10-20 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 82 | mg/dL | <=129 mg/dL | Normal | S |
| 2026-10-20 | Triglyceride [Mass/volume] in Serum or Plasma | 124 | mg/dL | <=149 mg/dL | Normal | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-08-03 | Body height | 175 | cm | S |
| 2026-08-03 | Body weight | 74.2 | kg | S |
| 2026-08-03 | Body mass index (BMI) [Ratio] | 24.2 | kg/m2 | S |
| 2026-08-03 | Systolic blood pressure | 136 | mm[Hg] | S |
| 2026-08-03 | Diastolic blood pressure | 82 | mm[Hg] | S |
| 2026-08-03 | Heart rate | 72 | /min | S |
| 2026-08-03 | Respiratory rate | 14 | /min | S |
| 2026-08-03 | Body temperature | 36.6 | Cel | S |
| 2026-08-03 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 2026-08-17 | Body height | 175 | cm | S |
| 2026-08-17 | Body weight | 74 | kg | S |
| 2026-08-17 | Body mass index (BMI) [Ratio] | 24.2 | kg/m2 | S |
| 2026-08-17 | Systolic blood pressure | 128 | mm[Hg] | S |
| 2026-08-17 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 2026-08-17 | Heart rate | 70 | /min | S |
| 2026-08-17 | Respiratory rate | 14 | /min | S |
| 2026-08-17 | Body temperature | 36.5 | Cel | S |
| 2026-08-17 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 2026-09-14 | Body height | 175 | cm | S |
| 2026-09-14 | Body weight | 73.8 | kg | S |
| 2026-09-14 | Body mass index (BMI) [Ratio] | 24.1 | kg/m2 | S |
| 2026-09-14 | Systolic blood pressure | 126 | mm[Hg] | S |
| 2026-09-14 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 2026-09-14 | Heart rate | 68 | /min | S |
| 2026-09-14 | Respiratory rate | 14 | /min | S |
| 2026-09-14 | Body temperature | 36.6 | Cel | S |
| 2026-09-14 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 2026-09-24 | Body height | 175 | cm | S |
| 2026-09-24 | Body weight | 73.9 | kg | S |
| 2026-09-24 | Body mass index (BMI) [Ratio] | 24.1 | kg/m2 | S |
| 2026-09-24 | Systolic blood pressure | 124 | mm[Hg] | S |
| 2026-09-24 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 2026-09-24 | Heart rate | 74 | /min | S |
| 2026-09-24 | Respiratory rate | 14 | /min | S |
| 2026-09-24 | Body temperature | 36.9 | Cel | S |
| 2026-09-24 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 2026-10-01 | Body height | 175 | cm | S |
| 2026-10-01 | Body weight | 74.1 | kg | S |
| 2026-10-01 | Body mass index (BMI) [Ratio] | 24.2 | kg/m2 | S |
| 2026-10-01 | Systolic blood pressure | 128 | mm[Hg] | S |
| 2026-10-01 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 2026-10-01 | Heart rate | 68 | /min | S |
| 2026-10-01 | Respiratory rate | 14 | /min | S |
| 2026-10-01 | Body temperature | 36.6 | Cel | S |
| 2026-10-01 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 2026-10-20 | Body height | 175 | cm | S |
| 2026-10-20 | Body weight | 73.6 | kg | S |
| 2026-10-20 | Body mass index (BMI) [Ratio] | 24 | kg/m2 | S |
| 2026-10-20 | Systolic blood pressure | 124 | mm[Hg] | S |
| 2026-10-20 | Diastolic blood pressure | 74 | mm[Hg] | S |
| 2026-10-20 | Heart rate | 66 | /min | S |
| 2026-10-20 | Respiratory rate | 14 | /min | S |
| 2026-10-20 | Body temperature | 36.5 | Cel | S |
| 2026-10-20 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Purpose | Status | Provenance |
|---|---|---|---|
| 2026-08-03 | Primary care visit for weakness, numbness, and curling of the ring and little fingers of the right hand after a fall onto the elbow, with same-day brain MRI and elbow X-ray | finished | S |
| 2026-08-17 | Two-week review with nerve conduction studies, EMG, and nerve ultrasound; diagnosis; hand surgery consultation; start of splinting, hand therapy, and a statin | finished | S |
| 2026-09-14 | Four-week review of the ulnar neuropathy on splinting and hand therapy | finished | S |
| 2026-10-20 | Nine-week review of the ulnar neuropathy and lipids; shared decision on surgery | finished | S |
| 2026-09-24 | Same-day sick visit for red, watery eyes | finished | S |
| 2026-10-01 | Subsequent annual wellness visit | finished | S |
| Intervention | Status | Guideline | Provenance |
|---|---|---|---|
| Same-day assessment for stroke and localization: full neurological examination and NIH Stroke Scale, MRI of the brain with diffusion-weighted imaging, X-ray of the right elbow, and an ECG | completed | GL-AHA-STROKE-2021, GL-AAOS-UNE, GL-COCHRANE-UNE-2025, GL-AANEM-UNE-1999 | S |
| Hand surgery consultation with nerve conduction studies, EMG, and ultrasound of the ulnar nerve, to confirm the site and severity and to advise on splinting, hand therapy, and surgery | completed | GL-AAOS-UNE, GL-COCHRANE-UNE-2025, GL-AANEM-UNE-1999 | S |
| Protect the nerve now: no leaning on the right elbow (a gel elbow pad and a padded armrest at the drawing table), avoid prolonged elbow bending, a towel loosely wrapped around the elbow at night until a splint is made; acetaminophen for pain | completed | GL-AAOS-UNE, GL-COCHRANE-UNE-2025, GL-AANEM-UNE-1999 | S |
| Stroke risk-factor screen: blood pressure at every visit with a week of home readings, lipid panel with lipoprotein(a), HbA1c, ECG, and pulse check for atrial fibrillation | completed | GL-AHA-STROKE-2021, GL-ACC-PREV-2019, GL-CMID-2026, GL-ACC-CHOL-2018, GL-USPSTF-STATIN-2022 | S |
| Conservative treatment of the ulnar neuropathy for about three months: night elbow splint, daytime anti-claw splint, hand therapy for strength, dexterity, and adapted tools (built-up brush handles, an easel-mounted palette, a lighter brush), with grip and pinch dynamometry and two-point discrimination at each review; no corticosteroid injection | completed | GL-AAOS-UNE, GL-COCHRANE-UNE-2025, GL-AANEM-UNE-1999 | S |
| Shared decision on a statin for primary prevention: atorvastatin 20 mg each evening, a lipid panel 4 to 12 weeks after starting, and adherence and muscle-symptom review at each visit | completed | GL-CMID-2026, GL-ACC-CHOL-2018, GL-USPSTF-STATIN-2022, GL-ACC-PREV-2019 | S |
| Shared decision on surgery if strength has not improved by about three months: in situ decompression of the ulnar nerve at the elbow (anterior transposition only if the nerve subluxes at operation); tendon transfers to correct the claw only if it persists a year or more after decompression | completed | GL-AAOS-UNE, GL-COCHRANE-UNE-2025, GL-AANEM-UNE-1999 | S |
| Falls: a handrail on both sides of the stone staircase, night lighting, footwear review, and a Timed Up and Go at the wellness visit | completed | GL-USPSTF-FALLS-2024 | S |
| Goal | Target | Status | Outcome | Provenance |
|---|---|---|---|---|
| Stroke excluded and the lesion localized by the second visit | 2026-08-17 | completed | Normal neurological examination apart from the right ulnar territory; MRI brain normal; nerve conduction studies, EMG, and ultrasound confirm ulnar neuropathy at the elbow | S |
| Keep working: drawing, writing, and teaching with the left hand, and painting with adapted tools and help | 2027-02-01 | active | Drawing and teaching fully; painting small panels with an easel palette and built-up brushes | S |
| Recovery of ulnar sensation and intrinsic strength, judged at about three months from the injury | 2027-02-01 | active | Sensation improving; first dorsal interosseous still 3+/5 with clawing at nine weeks; decompression booked | S |
| LDL down by 30 to 49 percent on a moderate-intensity statin | 2026-10-20 | completed | LDL 146 to 82 mg/dL (44 percent) after nine weeks of atorvastatin 20 mg | S |
| No further falls | 2027-08-01 | active | No falls since the injury; handrail fitted and stair lighting added | S |